Reflux, surgery, antireflux, fundoplication, icg
Conditions
Interventions
The main endpoint of this study is the observation of a perfusion defect in the spleen and/or gastric fundus. This endpoint will be measured by visual inspection of the blood flow of the spleen and ga
Sponsors
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands
Eligibility
Inclusion criteria
Inclusion criteria: - Age =18 - Objectively proven GERD (by gastroscopy, manometry, 24-hour pH and/or impedance monitoring) - Written informed consent for study participation
Exclusion criteria
Exclusion criteria: - Age <18 - Pregnancy - Breastfeeding - Achalasia - Previous gastric surgery - Previous esophageal surgery - Inability to understand the Dutch language - Inability to understand and/or fill in the informed consent form - Adverse reactions to indocyanine green, sodium iodide or iodide - Hyperthyroidism, thyroid adenoma - Liver insufficiency - Reduced kidney function as defined by a Glomerular Filtration Rate of < 40
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main endpoint of this study is the observation of a perfusion defect in the spleen and/or gastric fundus. Possible observations are no perfusion defect, possible perfusion defect and definite perfusion defect in one or both organs. | — |
Secondary
| Measure | Time frame |
|---|---|
| The quality of the assessment of perfusion will be scored as adequate or inadequate. | — |
Contacts
Public ContactWA Draaisma
-
Outcome results
None listed